Accepted at: Feb, 04, 2025 10:01 a.m.
Author: alexlewis
Related Deck: 1675118865074
Accepted
Rationale for new note

GOLD Guidelines

Text
GOLD Guidelines
Initial pharmacological treatment for COPD in a patient with moderate or worse symptoms and ≤2 moderate exacerbations yearly, without hospitalisation

{{c1::LABA + LAMA}}
Extra
≥2 moderate exacerbations
OR
 ≥1 leading to hospitalisation
Group E
LABA + LAMA
Consider LABA+LAMA+ICS if eosinophils ≥300μL
≤2 moderate exacerbations
(not leading to hospital admission)
Group A
A bronchodilator
Group B
LABA + LAMA
mMRC 0-1, CAT <10 mMRC ≥2, CAT ≥10
Personal Notes
Empty field
Missed Questions
Empty field
Oxford Handbook
Empty field
First Aid
Empty field
AMBOSS
Empty field
eTG Complete
Empty field
Talley & O'Connor
Empty field
Additional Resources
Empty field
Source
GOLD 2025 Report Accessed 31 January 2025
One by one
Empty field
Tags
#Malleus_CM::#Guidelines::International::GOLD #Malleus_CM::#Subjects::Respiratory_Medicine::05_Lungs::01_Obstructive::COPD::08_Diagnosis/Investigations #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Respiratory_Medicine #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine #Malleus_CM::#Resources_by_Rotation::Emergency #Malleus_CM::#Resources_by_Rotation::Intensive_Care #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Geriatric_Medicine #Malleus_CM::#Resources_by_Rotation::General_Practice #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Palliative_Care #Malleus_CM::#Yield::High